Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Brian J. Druker, Nicholas B. Lydon

Published in Volume 105, Issue 1

J Clin Invest. 2000; 105(1):3 doi:10.1172/JCI9083

Full text | PDF

Download citation in the following formats

• BibTex for BibDesk, Connotea, refbase
• RIS for Endnote, ProCite, Reference Manager
• Reference Manager (Windows)

If you experience problems using these citation formats, please send us feedback.